Influenza vaccine (live attenuated) nasal spray suspension of a composition that has been approved for use in the European Union for the season in question
|
Influenza vaccine nasal spray, suspension
|
By intranasal administration only
|
Prevention of seasonal influenza
|
Children and adolescents from 24 months:
0.2 ml (administered as 0.1 ml per nostril) in accordance with the summary of product characteristics of the product administered and Immunisation Guidelines for Ireland, as published and updated by the National Immunisation Advisory Committee of the Royal College of Physicians of Ireland.
|